Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 24

Results For "Max"

328 News Found

Live Pharma Coalition organised its first-ever pharma conclave in Mumbai
News | March 28, 2022

Live Pharma Coalition organised its first-ever pharma conclave in Mumbai

It celebrated its 100th session as LPC-100 in association with Mundial Pharma


Bar Ilan University launches course on 3D printing in medicine
News | March 25, 2022

Bar Ilan University launches course on 3D printing in medicine

A new course at the Azrieli Faculty of Medicine will focus on tissue regeneration and 3D printing for therapeutic needs


Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh
News | March 24, 2022

Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh

Kiran will be joining RSE's current Fellowship of around 1,700 Fellows who are recognized as being some of the greatest thinkers, researchers and practitioners working in or with Scotland


Waters introduces  automated solutions for mass and purity analysis of biomolecules
Biotech | March 23, 2022

Waters introduces automated solutions for mass and purity analysis of biomolecules

New line of Waters MaxPeak Premier columns further enhances the analysis by delivering 2x to 3x greater sensitivity than conventional steel columns


Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases
Biotech | March 23, 2022

Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases

This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies


Bristol Myers Squibb to demonstrate growing cardiovascular portfolio
Biotech | March 22, 2022

Bristol Myers Squibb to demonstrate growing cardiovascular portfolio

New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease


BASF and Beyond Suncare renew their cooperation to protect people with albinism in Africa
Sustainability | March 17, 2022

BASF and Beyond Suncare renew their cooperation to protect people with albinism in Africa

Over the next three years, BASF will continue to support Beyond Suncare by supplying the required raw materials free of charge and by providing technical expertise to further improve the formulation


Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments
News | March 15, 2022

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments

Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023


Illumina unveils pathbreaking genomic profiling test for cancer in Europe
Medical Device | March 15, 2022

Illumina unveils pathbreaking genomic profiling test for cancer in Europe

The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey